Gustave Roussy, Cancer Campus, Grand Paris

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website

Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer

Not Applicable
Conditions
Interventions
First Posted Date
2018-08-03
Last Posted Date
2018-08-03
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
50
Registration Number
NCT03613194
Locations
🇫🇷

Gustave Roussy, Villejuif, Val De Marne, France

Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab

First Posted Date
2018-08-02
Last Posted Date
2024-12-13
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
189
Registration Number
NCT03612791
Locations
🇫🇷

Gustave Roussy, Villejuif, Val De Marne, France

Neurocognitive Risks in Children With Solid Tumors

First Posted Date
2018-08-01
Last Posted Date
2024-12-13
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
1000
Registration Number
NCT03609112
Locations
🇫🇷

Gustave Roussy, Villejuif, Val De Marne, France

Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study

Not Applicable
Conditions
Interventions
First Posted Date
2018-07-30
Last Posted Date
2019-01-04
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
20
Registration Number
NCT03606070
Locations
🇫🇷

Gustave Roussy, Villejuif, Val De Marne, France

Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers

Not Applicable
Conditions
Interventions
First Posted Date
2018-07-27
Last Posted Date
2018-07-27
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
40
Registration Number
NCT03604588
Locations
🇫🇷

Gustave Roussy, Villejuif, Val De Marne, France

Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2018-07-27
Last Posted Date
2024-05-29
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
500
Registration Number
NCT03604627
Locations
🇫🇷

Hôpital Bichat, Paris, France

🇫🇷

Gustave Roussy, Villejuif, Val De Marne, France

🇫🇷

Hôpital Trousseau, Paris, France

Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer

First Posted Date
2018-07-23
Last Posted Date
2024-10-18
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
47
Registration Number
NCT03596281
Locations
🇫🇷

Gustave Roussy, Villejuif, Val de Marne, France

Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma

First Posted Date
2018-01-23
Last Posted Date
2024-03-28
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
140
Registration Number
NCT03406247
Locations
🇫🇷

Gustave Roussy, Villejuif, Val De Marne, France

© Copyright 2024. All Rights Reserved by MedPath